Goldman Sachs’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,756
| Closed | -$16.7K | – | 4935 |
|
|
2024
Q2 | $16.7K | Buy |
1,756
+193
| +12% | +$1.83K | ﹤0.01% | 4615 |
|
|
2024
Q1 | $14.2K | Sell |
1,563
-443
| -22% | -$4.02K | ﹤0.01% | 4631 |
|
|
2023
Q4 | $21.5K | Buy |
2,006
+275
| +16% | +$2.94K | ﹤0.01% | 4606 |
|
|
2023
Q3 | $19K | Buy |
1,731
+30
| +2% | +$330 | ﹤0.01% | 4566 |
|
|
2023
Q2 | $35.7K | Buy |
+1,701
| New | +$35.7K | ﹤0.01% | 4704 |
|